Literature DB >> 9785743

Late-life depression in primary care: where do we go from here?

D A Banazak1, C Wills, C Collins.   

Abstract

One quarter of elderly patients in the primary care physician's office experience serious depressive symptoms. Despite efforts over the past 20 years to increase detection of late-life depression in primary care settings, patient outcomes have not improved. Undertreatment remains seriously problematic. Current efforts to improve recognition have included the development of depression practice guidelines, Depression Awareness Recognition and Treatment (D/ART) program, educational programs, and rudimentary outcomes measures. Screening tools for depression, such as the Geriatric Depression Scale, the Center for Epidemiologic Studies--Depressed, and Cornell Scale for Depression in Dementia, have also been developed to help clinicians screen for depressive symptoms in both ambulatory and inpatient settings. However, to improve clinical outcomes, increased research efforts should focus upon physicians' attitudes and practice patterns, effective treatments for minor depression, and effective ways to assess patients' perceptions of depression, as well as ways to identify age-specific barriers to treatment adherence. In addition, incorporating valid outcome measures into the primary care clinical setting will be crucial to measure the impact of our treatments.

Entities:  

Mesh:

Year:  1998        PMID: 9785743

Source DB:  PubMed          Journal:  J Am Osteopath Assoc        ISSN: 0098-6151


  2 in total

1.  What we talk about when we talk about depression: doctor-patient conversations and treatment decision outcomes.

Authors:  Alison Karasz; Christopher Dowrick; Richard Byng; Marta Buszewicz; Lucia Ferri; Tim C Olde Hartman; Sandra van Dulmen; Evelyn van Weel-Baumgarten; Joanne Reeve
Journal:  Br J Gen Pract       Date:  2012-01       Impact factor: 5.386

2.  Trends in elderly patients' office visits for the treatment of depression according to physician specialty: 1985-1999.

Authors:  Jeffrey S Harman; Stephen Crystal; James Walkup; Mark Olfson
Journal:  J Behav Health Serv Res       Date:  2003 Jul-Sep       Impact factor: 1.505

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.